Shingrix was originally approved by the FDA in 2017 for the prevention of shingles in adults 50 years and older. Now, it’s approved for those 18 years and older who are immunocompromised.
Armand Butera
Advertisement
Articles by Armand Butera
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Infection Control Today
1
What Is the IP Paradox? Numbers Tell the Story of Underresourced Experts in a High-Stakes Environment
2
Leprosy Today: What Infection Preventionists Still Need to Know
3
Flu Season Equipment Readiness: How Hospitals Can Prevent Shortages, Support Infection Prevention, and Manage Surges
4
Honoring William Foege, MD, MPH: The Architect of Smallpox Eradication and Modern Outbreak Control
5